- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07941037
Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand
Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
This clinical trial will investigate whether non-compressive therapeutic gloves improve hand function and reduce pain in people with hand osteoarthritis. The gloves contain semiconductor elements embedded in their fabric. Researchers will compare these gloves with visually identical placebo gloves that do not contain semiconductor elements.
The main question is whether the active gloves improve hand function after 12 weeks compared with placebo gloves. Researchers will also assess pain, grip strength, symptoms and changes seen on magnetic resonance imaging (MRI) over nine months.
The study will involve at least 154 participants aged 39 years or older with diagnosed hand osteoarthritis who do not require immediate hand surgery. It will take place at MSK House in Sleaford, United Kingdom.
After providing written informed consent, participants will be assigned by chance to one of two groups. Each participant will have an equal chance of receiving active or placebo gloves. Neither participants nor the clinical team will know which gloves have been assigned.
Participants will:
- Wear the assigned glove or gloves on their affected hand or hands for at least 20 hours each day, including overnight, during the first 12 weeks.
- Continue wearing the gloves for at least 12 hours each day, including overnight, for the remainder of the nine-month study.
- Complete questionnaires about hand pain and function before treatment and at three, six and nine months.
- Attend the study site at the beginning and at nine months for assessments, including grip strength testing and MRI scans of the hand and wrist.
- Record their hand pain, glove use and pain medication use in a weekly diary.
Participants may also complete a short video-based movement assessment at the first and last study visits.
The main measure of hand function will be the Australian Canadian Osteoarthritis Hand Index (AUSCAN), a questionnaire about hand symptoms and difficulty with everyday activities. Other assessments will measure pain, hand function, grip strength and changes in the hand joints.
The research team will record unwanted effects during the study. Participants who experience discomfort, irritation or a skin reaction will be advised to remove the gloves and contact the study team.
The findings will help determine whether these therapeutic gloves have a role in managing hand osteoarthritis.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Paul Lee
- Numéro de téléphone: +44 330 001 0048
- E-mail: research@mskdoctors.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosed erosive hand osteoarthritis, non-erosive hand osteoarthritis or first carpometacarpal joint osteoarthritis.
- Mild, moderate or severe hand osteoarthritis on MRI assessment, without an indication for immediate surgery.
- Hand pain attributable to diagnosed hand osteoarthritis within the previous six months.
- Aged 39 years or older.
- Willing and able to comply with the follow-up schedule and study requirements.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Known history of neurological conditions, including multiple sclerosis or Parkinson's disease.
- Surgical treatment of the hands within the previous five years or injection treatment of the hands within the previous six months.
- An indication for immediate surgery to treat hand osteoarthritis.
- Secondary causes of arthritis, including gout, rheumatoid arthritis or psoriatic arthritis.
- Use of topical creams or gels for arthritic pain within the previous week, including non-steroidal anti-inflammatory drugs, capsaicin, lidocaine or counterirritants.
- History of carpal tunnel syndrome, cubital tunnel syndrome or radial tunnel syndrome.
- History of peripheral neuropathy.
- Chronic pain conditions unrelated to the hand condition.
- Known autoimmune disease other than arthritis.
- Tobacco use within the previous 90 days.
- Aged under 39 years.
- Active local or systemic infection.
- Unwilling or unable to provide written informed consent.
- Any other condition or circumstance that, in the investigator's opinion, would prevent completion of the study or confound the study results.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Icrediwear Group
Participants receive active semiconductor-embedded gloves to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Non-compressive therapeutic gloves with semiconductor elements incorporated into the fabric. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
|
Comparateur placebo: Placebo Group
Participants receive identical gloves without semiconductor elements to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Visually identical non-compressive gloves without semiconductor elements. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Change in Hand Function Assessed Using the Australian Canadian Osteoarthritis Hand Index (AUSCAN)
Délai: Baseline and 12 weeks
|
Baseline and 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Change in Hand Pain Assessed Using a Visual Analogue Scale
Délai: Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Functional Index for Hand Osteoarthritis (FIHOA) Score
Délai: Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Grip Strength
Délai: Baseline and month 9.
|
Baseline and month 9.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 2024-24
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .